Evidence map›Paper›PMID 26569102›Full record

ArticlePloS one2015

A Chemical Screening Approach to Identify Novel Key Mediators of Erythroid Enucleation.

Christina B Wölwer, Luke B Pase, Helen B Pearson, Nathan J Gödde, Kurt Lackovic, David C S Huang, Sarah M Russell, Patrick O Humbert

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Blood Pharming of Red Cells.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2026
    Review
  3. Article
  4. Erythroblast enucleation at a glance.Journal of cell science · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Christina B WölwerCell Cycle and Cancer Genetics, Peter MacCallum Cancer Centre, Melbourne, Australia.
Luke B PaseCell Cycle and Cancer Genetics, Peter MacCallum Cancer Centre, Melbourne, Australia.
Helen B PearsonCell Cycle and Cancer Genetics, Peter MacCallum Cancer Centre, Melbourne, Australia.
Nathan J GöddeCell Cycle and Cancer Genetics, Peter MacCallum Cancer Centre, Melbourne, Australia.
Kurt LackovicThe Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
David C S HuangThe Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
Sarah M RussellSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
Patrick O HumbertCell Cycle and Cancer Genetics, Peter MacCallum Cancer Centre, Melbourne, Australia.
Peter MacCallum Cancer Centre · AUUniversity of Melbourne · AUWalter and Eliza Hall Institute of Medical Research · AUSwinburne University of Technology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erythroid enucleation is critical for terminal differentiation of red blood cells, and involves extrusion of the nucleus by orthochromatic erythroblasts to produce reticulocytes. Due to the difficulty of synchronizing erythroblasts, the molecular mechanisms underlying the enucleation process remain poorly understood. To elucidate the cellular program governing enucleation, we utilized a novel chemical screening approach whereby orthochromatic cells primed for enucleation were enriched ex vivo and subjected to a functional drug screen using a 324 compound library consisting of structurally diverse, medicinally active and cell permeable drugs. Using this approach, we have confirmed the role of HDACs, proteasomal regulators and MAPK in erythroid enucleation and introduce a new role for Cyclin-dependent kinases, in particular CDK9, in this process. Importantly, we demonstrate that when coupled with imaging analysis, this approach provides a powerful means to identify and characterize rate limiting steps involved in the erythroid enucleation process.

Indexed as

AnimalsCell DifferentiationCell NucleusCell SeparationCyclin-Dependent Kinase 9ErythroblastsErythropoiesisFlow CytometryHistone DeacetylasesMAP Kinase Signaling SystemMiceMice, Inbred C57BLPhenotypeProteasome Endopeptidase ComplexProteasome InhibitorsReticulocytesCdk9 protein, mouseCyclin-Dependent Kinase 9Histone DeacetylasesProteasome Endopeptidase ComplexProteasome Inhibitors

Identifiers

PMID26569102
PMCPMC4646491
OpenAlexW2245242190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.